Juliane Bolbrinker

6PUBLICATIONS
13CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)GravimetricsHaematologyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 30, 2023
Studies in Zebrafish and Rat Models Support Dual Blockade of EP2 and EP4 (Prostaglandin E<sub>2</sub> Receptors Type 2 and 4) for Renoprotection in Glomerular Hyperfiltration and Albuminuria.

Aikaterini Kourpa, Angela Schulz, Eva Mangelsen

|Nov 28, 2022
Longitudinal effects of a common UMOD variant on kidney function, blood pressure, cognitive and physical function in older women and men.

Engi Abdel-Hady Algharably, Linda Elizabeth Villagomez Fuentes, Sarah Toepfer

|Oct 01, 2021
Effect of a common UMOD variant on kidney function, blood pressure, cognitive and physical function in a community-based cohort of older adults.

Linda Elizabeth Villagomez Fuentes, Engi Abdel-Hady Algharably, Sarah Toepfer

|May 23, 2020
Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E<sub>2</sub> Activation in Human Podocytes.

Eva Mangelsen, Michael Rothe, Angela Schulz

|May 26, 2017
Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.

Juliane Bolbrinker, Edeltraut Garbe, Antonios Douros

|May 24, 2017
European guidelines on lifestyle changes for management of hypertension : Awareness and implementation of recommendations among German and European physicians.

J Bolbrinker, L Zaidi Touis, H Gohlke

Pageof 1

Frequent Collaborators

2 joint publications

Eva Mangelsen

2 joint publications

Linda Elizabeth Villagomez Fuentes

2 joint publications

Ilja Demuth

1 joint publications

Engi Abdel-Hady Algharably